Quidel Corporation (QDEL): Price and Financial Metrics

Quidel Corporation (QDEL)

Today's Latest Price: $246.64 USD

1.68 (0.69%)

Updated Jul 10 4:00pm

Add QDEL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

QDEL Stock Summary

  • With a price/earnings ratio of 117.29, Quidel Corp P/E ratio is greater than that of about 94.62% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for QDEL is currently 63.64, higher than 95.12% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of -37.46%, Quidel Corp's debt growth rate surpasses merely 7.54% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Quidel Corp, a group of peers worth examining would be NIU, LOGI, VAR, PAYC, and TECH.
  • Visit QDEL's SEC page to see the company's official filings. To visit the company's web site, go to www.quidel.com.
QDEL Daily Price Range
QDEL 52-Week Price Range

QDEL Stock Price Chart Technical Analysis Charts

QDEL Price/Volume Stats

Current price $246.64 52-week high $248.00
Prev. close $244.96 52-week low $52.49
Day low $242.02 Volume 523,307
Day high $247.22 Avg. volume 825,361
50-day MA $186.27 Dividend yield N/A
200-day MA $104.52 Market Cap 10.36B

Quidel Corporation (QDEL) Company Bio

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, women’s health, and gastrointestinal diseases. The company was founded in 1979 and is based in San Diego, California.

QDEL Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

We started the process of determining a valid price forecast for Quidel Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Quidel Corp ranked in the 59th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for Quidel Corp ended up being:

  • The company's balance sheet shows it gets 99% of its capital from equity, and 1% of its capital from debt. Its equity weight surpasses that of 88.91% of free cash flow generating stocks in the Healthcare sector.
  • The business' balance sheet reveals debt to be 1% of the company's capital (with equity being the remaining amount). Approximately just 5.46% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • QDEL's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 54.69% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as QDEL, try CBPO, PBH, UTHR, ANTM, and UHS.

QDEL Latest News Stream

Event/TimeNews Detail
Loading, please wait...

QDEL Latest Social Stream

Loading social stream, please wait...

View Full QDEL Social Stream

Latest QDEL News From Around the Web

Below are the latest news stories about Quidel Corp that investors may wish to consider to help them evaluate QDEL as an investment opportunity.

Quidel (QDEL) Gains But Lags Market: What You Should Know

Quidel (QDEL) closed at $246.64 in the latest trading session, marking a +0.69% move from the prior day.

Yahoo | July 10, 2020

3 Reasons Why Growth Investors Shouldn't Overlook Quidel (QDEL)

Quidel (QDEL) possesses solid growth attributes, which could help it handily outperform the market.

Yahoo | July 10, 2020

Are These Medical Stocks Cruising Toward Big Gains? Here's A Bullish Sign

Medical stocks could be making a comeback this year. The best-performing among them include medical technology companies with high Composite Ratings, a key metric measuring growth.

Yahoo | July 9, 2020

Why Quidel Stock Rose 28% in June

What happened Shares of Quidel (NASDAQ: QDEL), which makes diagnostic healthcare products, popped 27.9% in June, according to data from S&P Global Market Intelligence. The S&P 500 returned 2% last month.

Yahoo | July 8, 2020

The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) * ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) * Akero Therapeutics Inc (NASDAQ: AKRO) * Amgen, Inc. (NASDAQ: AMGN) * Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) * Champions Oncology Inc (NASDAQ: CSBR) * Crispr Therapeutics AG (NASDAQ: CRSP) * Cytokinetics, Inc. (NASDAQ: CYTK) * DexCom, Inc. (NASDAQ: DXCM) * Eli Lilly And Co (NYSE: LLY) * Fate Therapeutics Inc (NASDAQ: FATE) * GENMAB A/S/S ADR (NASDAQ: GMAB) * Halozyme Therapeutics, Inc. (NASDAQ: HALO) * Hologic, Inc. (NASDAQ: HOLX) * Horizon Therapeutics PLC (NASDAQ: HZNP) * Illumina, Inc. (NASDAQ: ILMN) * Immunomedics, Inc. (NASDAQ: IMMU) (announced positive late-stage...

Yahoo | July 7, 2020

Read More 'QDEL' Stories Here

QDEL Price Returns

1-mo 55.74%
3-mo N/A
6-mo 208.61%
1-year 330.06%
3-year 804.11%
5-year 945.08%
YTD 228.72%
2019 53.69%
2018 12.62%
2017 102.38%
2016 1.04%
2015 -26.69%

Continue Researching QDEL

Here are a few links from around the web to help you further your research on Quidel Corp's stock as an investment opportunity:

Quidel Corp (QDEL) Stock Price | Nasdaq
Quidel Corp (QDEL) Stock Quote, History and News - Yahoo Finance
Quidel Corp (QDEL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8915 seconds.